Texas Permanent School Fund’s Vanda Pharmaceuticals VNDA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q3
Sell
-49,789
Closed -$328K 1531
2023
Q2
$328K Sell
49,789
-368
-0.7% -$2.36K ﹤0.01% 1493
2023
Q1
$341K Buy
50,157
+12,333
+33% +$86.7K ﹤0.01% 1481
2022
Q4
$280K Sell
37,824
-2,621
-6% -$25.5K ﹤0.01% 1459
2022
Q3
$400K Sell
40,445
-146
-0.4% -$1.54K 0.01% 1397
2022
Q2
$442K Buy
40,591
+1,094
+3% +$11.3K 0.01% 1384
2022
Q1
$447K Sell
39,497
-668
-2% -$8.78K 0.01% 1416
2021
Q4
$630K Sell
40,165
-992
-2% -$17.3K 0.01% 1353
2021
Q3
$705K Sell
41,157
-249
-0.6% -$4.36K 0.01% 1325
2021
Q2
$891K Buy
41,406
+403
+1% +$7.21K 0.01% 1253
2021
Q1
$616K Sell
41,003
-2,912
-7% -$47.1K 0.01% 1360
2020
Q4
$577K Sell
43,915
-7,135
-14% -$85.9K 0.01% 1343
2020
Q3
$493K Buy
51,050
+8,194
+19% +$87.6K 0.01% 1339
2020
Q2
$490K Sell
42,856
-2,515
-6% -$28.5K 0.01% 1285
2020
Q1
$470K Buy
45,371
+8,888
+24% +$110K 0.01% 1243
2019
Q4
$599K Buy
36,483
+223
+0.6% +$3.37K 0.01% 1274
2019
Q3
$482K Buy
36,260
+315
+0.9% +$4.39K 0.01% 1313
2019
Q2
$506K Buy
35,945
+201
+0.6% +$3.2K 0.01% 1301
2019
Q1
$658K Buy
35,744
+1,421
+4% +$32.4K 0.01% 1238
2018
Q4
$897K Buy
34,323
+1,377
+4% +$32.4K 0.02% 1056
2018
Q3
$756K Buy
+32,946
New +$673K 0.01% 1215

Other funds holding VNDA

Texas Permanent School Fund's VNDA Position: Q3 2023 in Review

Texas Permanent School Fund sold out of Vanda Pharmaceuticals (VNDA) in Q3 2023, closing a stake of 49,789 shares — an estimated $328K sold.

Texas Permanent School Fund first reported a position in VNDA in Q3 2018 and held it in 20 quarters. The position peaked at $897K in Q4 2018. 179 funds tracked by Wall St. Rank hold VNDA as of Q3 2023.

  • Texas Permanent School Fund reported no remaining Vanda Pharmaceuticals position as of Q3 2023 after selling out during the quarter.
  • Texas Permanent School Fund sold 49,789 Vanda Pharmaceuticals shares in Q3 2023, an estimated $328K.
  • Texas Permanent School Fund first reported a position in Vanda Pharmaceuticals in Q3 2018 and held it in 20 quarters.
  • Texas Permanent School Fund's Vanda Pharmaceuticals position peaked at $897K in Q4 2018.
  • 179 funds tracked by Wall St. Rank held Vanda Pharmaceuticals as of Q3 2023.

Based on Texas Permanent School Fund's 13F filing for Q3 2023, filed 9 Nov 2023.